Kiora Pharmaceuticals Partners with Global Genes to Advance Treatment for Rare Eye Disorders Kiora Pharmaceuticals has joined the RARE-X Vision Consortium, collaborating with Global Genes to enhance treatments for rare ocular conditions through innovative research and community involvement.

Kiora Pharmaceuticals Partners with Global Genes to Advance Treatment for Rare Eye Disorders #USA #Global_Genes #Encinitas #Kiora_Pharmaceuticals #RARE-X_Vision

Global Genes and Boston Children's Hospital Team Up for 2025 RARE Symposium on Drug Development Excellence The 2025 RARE Drug Development Symposium, hosted by Global Genes and Boston Children's Hospital, empowers advocates in rare disease research and therapy.

Global Genes and Boston Children's Hospital Team Up for 2025 RARE Symposium on Drug Development Excellence #United_States #Boston #Global_Genes #Boston_Children's #RARE_Symposium

Global Genes Receives $1.5 Million Grant to Enhance RARE-X Data Platform with AI Integration Global Genes secures a significant $1.5 million grant from Chan Zuckerberg Initiative to improve its RARE-X patient data platform using AI, aiding rare disease research.

Global Genes Receives $1.5 Million Grant to Enhance RARE-X Data Platform with AI Integration #USA #Washington #Global_Genes #Chan_Zuckerberg #RARE-X

Ongoing Patient Engagement: Key to Enhancing Rare Disease Trial Outcomes The recent white paper highlights the importance of patient engagement in rare disease clinical trials and its role in reducing costs and improving success rates.

Ongoing Patient Engagement: Key to Enhancing Rare Disease Trial Outcomes #United_States #Washington #Clinical_Trials #Rare_Diseases #Global_Genes